IMUX

IMMUNIC, INC.

Healthcare · Biotechnology

$241.49 sample

+3.29 (+1.38%) 1D

Market cap

$352.0B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-29

Alerts

8

Price$241.49 +1.04% 3M daily closessample

247.35226.50

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06INSInsider buy: 10% owner
Sep 29SEC8-K filed: material event
Sep 21SEC10-Q filed
Sep 10INSInsider sell: Director
Sep 02INSInsider buy: General Counsel
Aug 24INSInsider buy: General Counsel
Aug 13INSInsider sell: 10% owner
Aug 10SECDEF 14A filed

Sign up to see the real IMUX record →

Company facts

SEC EDGAR registration

Name: IMMUNIC, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +11sample, -100 to +100
Reporting currency: USD

Who is positioning in IMUX

sample

Insiders: 30 insider transactions over 90 days, net selling, $866.2M
Congress: No member trades over 90 days
Institutions · 13F: 34 funds hold $5.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.7B +23.2% y/y

Q4 2024Q3 2026

Inventory$6.3B +9.9% y/y

Q4 2024Q3 2026

Accounts receivable$4.8B +17.0% y/y

Q4 2024Q3 2026

Total debt$12.0B +8.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $346.6B +7.2% 3M
Sample peer B: $314.5B -0.6% 3M
Sample peer C: $198.5B +15.0% 3M
Sample peer D: $217.4B +16.2% 3M
Sample peer E: $55.0B +4.0% 3M